Bemærk: Kan ikke leveres før jul.
Forventes på lager: 23-05-2024
Development of Gene Therapies: Strategic, Scientific, and Regulatory, and Access Considerations attempts to summarize the current state-of-the-art strategic, scientific, statistical, and regulatory aspects of GTx development.
| Forlag | Taylor & Francis Ltd |
| Type | Bog |
| Format | Hardback |
| Sprog | Engelsk |
| Udgivelsesdato | 23-05-2024 |
| Første udgivelsesår | 2024 |
| Serie | Chapman & Hall/CRC Biostatistics Series |
| Illustrationer | 1 Tables, color; 19 Tables, black and white; 36 Line drawings, color; 1 Line drawings, black and white; 36 Illustrations, color; 1 Illustrations, black and white |
| Fagredaktør | Avery (Apellis Pharmaceuticals|Novartis McIntosh, Oleksandr (Apellis Pharmaceuticals|Novartis Sverdlov |
| Originalsprog | United Kingdom |
| Sideantal | 458 |
| Indbinding | Hardback |
| Forlag | Taylor & Francis Ltd |
| Sideoplysninger | 458 pages, 1 Tables, color; 19 Tables, black and white; 36 Line drawings, color; 1 Line drawings, bl |
| Mål | 254 x 178 |
| ISBN-13 / EAN-13 | 9781032136554 |